Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sheng Foong Pharmaceutical, officially known as Sheng Foong Co., Ltd., is a leading Taiwanese manufacturer of Traditional Chinese Medicine (TCM) and concentrated herbal extracts. Founded in 1989 and headquartered in Taipei, the company operates a sophisticated GMP-certified production facility in Yilan County, which is notable for its large-scale, powder-free herbal concentration technology. Sheng Foong offers an extensive portfolio of over 800 products, including single herbal extracts, classical compound formulas, pills, and capsules, which are distributed globally to clinical practitioners. The company maintains an ISO 17025-accredited laboratory to ensure high standards of quality and safety, specifically targeting the elimination of pesticide and heavy metal residues. Beyond commercial manufacturing, Sheng Foong actively participates in clinical research, notably supporting trials for adjunct oncological therapies such as Tien-Hsien Liquid.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sheng Foong Pharmaceutical.